Cargando…

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination

Detalles Bibliográficos
Autores principales:	Sookaromdee, Pathum, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Magdi Yacoub Heart Foundation 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629291/ https://www.ncbi.nlm.nih.gov/pubmed/36339680 http://dx.doi.org/10.21542/gcsp.2022.7

Ejemplares similares

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Temporal metabolic response and mRNA COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Relapsed Disciform Stromal Herpetic Keratitis and mRNA COVID-19 Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cardiac Tamponade and COVID-19 Vaccination: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Correspondence on COVID-19 Vaccination and Acquired Haemophila A
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Ipsilateral Lymphadenopathy, COVID-19 Vaccination and Breast Cancer
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Acute Myocardial Injury Following COVID-19 Vaccination
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Tachycardia, adverse effect, COVID-19 vaccine: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Tachycardia, adverse effect, COVID-19 vaccine: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Concurrent administration of COVID-19 vaccine and seasonal influenza vaccine: No increased estimated vaccine-related mortality rate
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

CMR Imaging After Myocarditis Associated with mRNA COVID-19 Vaccine: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Early COVID-19 Vaccine Hesitancy and Bariatric Surgery: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 health information sources and vaccine hesitancy: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 vaccine-related psychiatric adverse events: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Social communication pathways to COVID-19 vaccine side-effect correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

COVID-19 Vaccine-Induced Immune Response in Oral Fluids and Serum: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Comments on: Bilateral multifocal choroiditis with disc edema following COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

New COVID-19 Vaccines, Its Cost and Shelf Life: A Cost Effectiveness Analysis
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Positive Predictive Value of SARS-CoV-2 Spike Protein Antibody Test after COVID-19 Vaccination Policies
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Re: Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients by Peghin et al.
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Adverse events following immunisation (AEFI) after first dose of COVID-19 vaccine
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Monitoring of cases of anosmia and COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Role of Vitamin D in COVID-19: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Correspondence on artificial intelligence algorithm for COVID-19 pneumonia
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Persistent COVID-19 symptoms after diagnosis: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Estradiol, Immune-Protective Function and COVID-19: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 among medical personnel in the operating room
por: Sookaromdee, Pathum, et al.
Publicado: (2020)

COVID-19 and Underlying Cerebrovascular Disease: Analysis on Association
por: Sookaromdee, Pathum, et al.
Publicado: (2020)

Acetylsalicylic Acid and COVID-19 Prevention: A Comment
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Hospital-acquired infections during COVID-19 pandemic: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Dead Body of the Patient with COVID-19 and Concern on Disease Spreading
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_53j5em2l6dcs0p9f2873d9qe8i